Edition:
United Kingdom

Probi AB (PROB.ST)

PROB.ST on Stockholm Stock Exchange

423.00SEK
21 Sep 2018
Change (% chg)

3.00kr (+0.71%)
Prev Close
420.00kr
Open
420.00kr
Day's High
430.00kr
Day's Low
420.00kr
Volume
2,510
Avg. Vol
7,754
52-wk High
516.00kr
52-wk Low
298.50kr

Summary

Name Age Since Current Position

Jean-Yves Parisot

54 2015 Chairman of the Board

Ole Soegaard Andersen

66 2018 Interim Chief Executive Officer

Jorn Andreas

38 2017 Chief Financial Officer

Niklas Brandt

59 2017 Chief Information Officer and Investor Relations

Niklas Bjarum

55 2017 Vice President America, President of Probi USA Inc.

Linda Neckmar

45 2017 Vice President EMEA and APAC

Scott Bush

62 2017 Independent Director

Irene Corthesy Malnoe

60 2018 Director

Charlotte Hansson

56 2017 Independent Director

Anna Malm Bernsten

57 2017 Independent Director

Jan Nilsson

65 2010 Independent Director

Jonny Olsson

54 2015 Independent Director

Biographies

Name Description

Jean-Yves Parisot

Dr. Jean-Yves Parisot has been Chairman of the Board of Probi Aktiebolag since April 23, 2015. He holds Master of Business Administration degree and Doctor in Veterinary Medicine degree. He is President of Diana, part of Symrise Group. He is also Chairman of the Board of VetAgroSup. He previously held senior positions at Air Liquide, Danisco, Rhodia Food, Rhone-Poulenc, Merial and Pfizer.

Ole Soegaard Andersen

Mr. Ole Soegaard Andersen has been Interim Chief Executive Officer of PROBI Aktiebolag since March 14, 2018. He is an international business leader with over 30 years’ experience in ingredients companies. He formerly held positions as President, Systems Division and Global Vice President Sales, Marketing & Application for Nutrition and Health, at DuPont. He also served on Danisco’s Board of Executives. He holds Master of Science in Economics, University of Aarhus, Denmark.

Jorn Andreas

Mr. Jorn Andreas no longer serves as Chief Financial Officer of Probi AB, effective as of around December 31, 2018. He has held the position since March 1, 2017. He was Member of the Board of Directors of the Company from April 29, 2014 until March 1, 2017. He has previously been Chief Integration Officer and Vice President, Finance, Symrise Aroma Molecules Division, Jacksonville, the United States. He formerly worked with The Boston Consulting Group, Hamburg, Germany and Bayer AG, Leverkusen, Germany. He holds a Doctorate in Philosophy in Economics from Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.

Niklas Brandt

Mr. Niklas Brandt has been Chief Information Officer and Investor Relations at Probi AB since March 1, 2017. He has previously been Chief Financial Officer of the Company since May 2008. He previously worked for six years as Chief Financial Officer of Moving AB. Before that, he had a number of senior positions within finance and administration in a number of companies, such as Tibnor and EF Education. He holds a degree in Business Administration from Lunds Universitet.

Niklas Bjarum

Mr. Niklas Bjarum has been Vice President America at Probi AB since 2017 and he is also President of Probi USA Inc. within the Company. He previously was Vice President of Marketing and Sales at Probi AB from February 2001 till 2017. After receiving hid degree in 1988, he served in a number of positions in sales, marketing and business development of both strategic and operative character in Nestle and Masterfoods (Mars Inc). In 1998, he changed sector and worked three years at Ericsson Mobile Communications with responsibility for business development in Europe. He holds a degree in International Business Administration from Lunds Universitet.

Linda Neckmar

Ms. Linda Neckmar has been Vice President EMEA and APAC at Probi AB since 2017. She has previously been Vice President of Operations at Probi AB since January 2016. She holds Master of Science in Chemical Engineering from Lund University. Linda Neckmar has experience from the biotechnology industry, in pharmaceutical development and international business development, marketing and sales. Linda was employed at Probi in 2011 with responsibility for Marketing and Sales Consumer Healthcare. Prior to this, she worked at BioInvent International AB and OxiGene Inc.

Scott Bush

Mr. Scott Bush has been Independent Director at PROBI Aktiebolag since May 4, 2017. He is Civil Engineer and holds Master of Business Administration and Bachelor of Science degrees. He is Owner and CEO of Probiotic Consulting LLC. Previously, he held senior positions at DuPont, Danisco and Rhodia. He is Board Member of International Probiotics Association.

Irene Corthesy Malnoe

Ms. Irene Corthesy Malnoe has been Independent Director at PROBI Aktiebolag since May 2, 2018. She runs an independent business as senior consultant within Life Science. She has more than 25 years’ experience of research and development within biotechnology, health, food and beverages. She has previously held senior R&D positions within the Nestle Group and at Lausanne University Hospital. She holds Ph.D. in Molecular Biology from University of Lausanne.

Charlotte Hansson

Ms. Charlotte G. Hansson has been Independent Director at PROBI Aktiebolag since May 4, 2017. She is CEO of MorgonTidig Distribution KB. She previously held senior positions at Jetpak Group AB, Danzas ASG Eurocargo AB and Carl Zeiss AB. She is Board Member of Orio AB, DistIT AB, BE Group AB and Momentum Group AB. She is Candidate of Sciences in Biochemistry from Koebenhavns universitet and studied Market& Economics at IHM.

Anna Malm Bernsten

Ms. Anna Malm Bernsten has been Independent Director at PROBI Aktiebolag since May 4, 2017. She is Owner and CEO of Bernsten Konsult AB. Previously, she held senior positions at Oatly, GE Healthcare Life Sciences, ASSA ABLOY and Pharmacia & Upjohn, among others. She is Board Member of Medivir, Bjorn Axen, Cellavision and Pagen. She holds Master of Science degree in Chemical Engineering from Kungliga Tekniska Hogskolan.

Jan Nilsson

Mr. Jan Nilsson has been Independent Member of the Board of Directors of Probi AB since 2010. He is Member of the Board of Atherioco AB, PetaJoule AB,Cardiovax, the Swedish Research Council and MedScienta AB. He is Professor of Experimental Cardiovascular Research at Lunds Universitet. He was previously, among others, Dean at the Faculty of Medicine at Lunds Universitet between 2000 and 2005 and Deputy Secretary General for Medicinska forskningsradet (Medical Research Council) between 1995 and 1999. He holds a Doctorate of Medicine from Karolinska Institutet and a degree in Medicine from Karolinska Institutet.

Jonny Olsson

Mr. Jonny Olsson has been Independent Director of PROBI Aktiebolag since April 23, 2015. He holds Master of Business Administration degree. He is Owner and CEO of Jonny Olsson Consulting AB. He previously held senior positions at Tetra Pak, Oriflame and Ericsson. He is Board Member of The Incredible Journey AB, NGI Denmark, Liquid Consulting Inc & AB.